Communiqués Immunovia AB

Actions

IMMNOV

SE0006091997

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq Stockholm 18:00:00 11/09/2026			Varia. 5j.	Varia. 1 janv.
0,1428 ^SEK	+0,56%		+10,19%	-37,09%

03/09	Six actions ont atteint un nouveau plus bas de 52 semaines aujourd'hui à la Bourse de Stockholm	FW
01/09	17 actions ont atteint un nouveau plus bas sur 52 semaines aujourd'hui à la Bourse de Stockholm	FW

Communiqués

13/08	Immunovia presents survey data showing strong patient support for blood-based tests to detect pancreatic cancer at an earlier stage	AQ
06/08	Immunovia Publishes Interim Report for April-June 2026	AQ
03/08	Immunovia invites to a presentation on the Q2 report 2026	AQ
15/06	Immunovia announces new performance data for PancreaSure ahead of upcoming application for Medicare coverage	AQ
10/06	Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure	AQ
13/05	BULLETIN FROM THE ANNUAL GENERAL MEETING ON 13 MAY 2026 IN IMMUNOVIA AB (PUBL)	AQ
11/05	Research update Immunovia, Q1 2026: Initial commercialisation phase on track	AQ
07/05	Immunovia Publishes Interim Report for January-March 2026	AQ
05/05	Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance	AQ
04/05	Immunovia : Proposal for resolution on (A) option program for board members; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for board members and B directed issue of warrants and approval of transfer of warrants 45758458 v6)	PU
04/05	Immunovia invites to a presentation on the Q1 report and 2026 objectives	AQ
14/04	Immunovia : Proposal for resolution on (A) option program for management and key persons; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for management and key persons and B directed issue of warrants and approval of transfer of warrants)	PU
14/04	Immunovia : Proposal for resolution on (A) option program for board members; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for board members and B directed issue of warrants and approval of transfer of warrants )	PU
14/04	Immunovia : Proposal for resolution on authorization of the board to resolve on new issue of shares (Proposal for resolution on authorization regarding issues)	PU
14/04	Immunovia : Annual Report (Immunovia AB publ Annual Report 2025)	PU
14/04	Immunovia : Notice to annual general meeting 2026 (notice of annual general meeting in immunovia ab publ)	PU
14/04	Immunovia : Statement from nomination committee (Statement from nomination committee 2026)	PU
13/04	NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)	AQ
10/04	Immunovia publishes the Annual Report for 2025	AQ
10/04	Immunovia : Remuneration Report (Remuneration Report 2026 Updated)	PU
25/02	Research update Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026	AQ
24/02	Immunovia Publishes Full Year Report for 2025	AQ
23/02	Immunovia : Invitation to presentation of Immunovia's Q4 2025 report	PU
23/02	Invitation to presentation of Immunovia’s Q4 2025 report	AQ
23/01	Immunovia attends Aktiespararna Life Science	AQ